Can someone explain why PEDigree wasn't re-started? I thought PED patients were highest responders in the P1a.
PED and PVC patients are excluded in the Nexus trial. What's the thinking here?
There are PED's in nexxus, only the location in the eye of the PED is controlled "no PED's in this certain location" is the way it's worded.
They didn't restart it as a separate trial to save money.
pfizer advised against it
and since pfizer will be opting in next january, better to do what pfizer says
Sentiment: Strong Buy